WHO ICTRP trial
Evaluation of adenosine efficacy in the treatment of ventricular tachycardia
IRCT20190929044919N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20190929044919N1 |
|---|---|
| Public title | Evaluation of adenosine efficacy in the treatment of ventricular tachycardia |
| Scientific title | Comparison of the Effectiveness of 6 mg and 12 mg Adenosine in the Treatment of Paroxysmal Supraventricular Tachycardia |
| Primary sponsor | Alborz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Paroxysmal Supraventricular tachycardia. Abnormalities of heart beat |
| Interventions | Intervention 1: Intervention group 1: a dose of 6 mg of adenosine is used, and in case of non-response, a dose of 12 mg, and again, in case of non-response, a dose of 12 mg is used along with Valsalva maneuver. Intervention 2: Intervention… |
| Registration date | Jun 16, 2020 |
| Target size | 142 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: